glp 1 regulations GLP-1 Patents and regulatory exclusivities on

3 It was approved by the US FDA in 2023 to treat obesity (Zepbound , Eli Lilly and Company, Indianapolis, IN, USA) which was initially approved to treat type 2 diabetes in 2022 (Mounjaro , Eli Lilly and Company) (Table 1)

The studies say yes

Transcribed by Descript About Brittyn Coleman, MS, RDN/LD Brittyn Coleman, MS, RDN/LD, is a distinguished Registered Dietitian and Autism Nutrition Expert, known for her innovative, sensory-friendly feeding approach to nutrition for children on the autism spectrum

Upregulation of NCOA4 significantly elevates intracellular iron levels, further promoting lipid peroxidation and ferroptosis (Masaldan et al., 2018)